These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4810120)

  • 21. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
    McLaughlin LF; Drummond O; MacGregor IR
    Thromb Haemost; 1992 Nov; 68(5):511-5. PubMed ID: 1455396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin complex concentrates for clinical use.
    Chandra S; Brummelhuis HG
    Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeder With a Clot: Thrombosis Following Treatment of Bleeding in a Child With Severe Hemophilia B.
    Goh MC; Lam JCM; Tan AM; Bhattacharyya R
    J Pediatr Hematol Oncol; 2021 May; 43(4):e561-e563. PubMed ID: 32769563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B.
    Martinowitz UP; Schulman S
    Acta Haematol; 1995; 94 Suppl 1():35-42. PubMed ID: 7571993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Christmas factor concentrates. The clinical use of several preparations.
    Tullis JL; Breen FA
    Bibl Haematol; 1970; 34():40-51. PubMed ID: 5436352
    [No Abstract]   [Full Text] [Related]  

  • 26. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.
    Köhler M; Hellstern P; Lechler E; Uberfuhr P; Müller-Berghaus G
    Thromb Haemost; 1998 Sep; 80(3):399-402. PubMed ID: 9759617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombogenicity of prothrombin complex concentrates.
    Köhler M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S13-7. PubMed ID: 10499904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effect of prothrombin derivative preparations on hemophilia B patients].
    Abe T; Wakabayashi K
    Rinsho Ketsueki; 1972 Aug; 13(4):535-9. PubMed ID: 4674848
    [No Abstract]   [Full Text] [Related]  

  • 29. Prothrombin complex concentrate.
    DeWitt RT; Feinstein DI
    Arch Intern Med; 1977 Sep; 137(9):1211-3. PubMed ID: 901090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Prothrombin-complex concentrates in liver disease.
    Lancet; 1975 Jul; 2(7926):188-9. PubMed ID: 49788
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
    Sonoda T; Solomon A; Krauss S; Cruz P; Jones FS; Levin J
    Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
    Barthels M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors--benefits and limitations.
    Lusher JM
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):49-52. PubMed ID: 7939776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
    Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E; Mannucci PM; Gringeri A; Tagariello G; Baudo F; Bauer KA; Rosenberg RD
    Thromb Haemost; 1994 Jun; 71(6):737-40. PubMed ID: 7974341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of prothrombin complex concentrates in anticoagulation.
    van Veen SQ; Strengers PF
    Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.
    Dusel CH; Grundmann C; Eich S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):405-11. PubMed ID: 15205589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.